publicaciones seleccionadas artículo académico Lentiviral vector followed by protein immunisation breaks tolerance against the self‐antigen Her1 and results in lung cancer immunotherapy. The Journal of Gene Medicine. 14:151-157. 2012 PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy. Oncoimmunology. 1:86-88. 2012 On the Mechanism of T cell receptor down-modulation and its physiological significance. The Journal of Bioscience and Medicine. 1:1-5. 2011 PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8 + T cells. EMBO Molecular Medicine. 3:581-592. 2011 Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis. Arthritis & Rheumatology. 63:84-95. 2011 HIV-1 Lentiviral vector immunogenicity is mediated by Toll-Like Receptor 3 (TLR3) and TLR7. Journal of Virology. 84:5627-5636. 2010
